跳至主要内容
临床试验/JPRN-UMIN000018240
JPRN-UMIN000018240已完成未知

A clinical study on the safety of Hypofractionated Whole Breast Irradiation with Concurrent Boost in Breast conserving therapy - A clinical study on the safety of Hypofractionated Whole Breast Irradiation with Concurrent Boost

Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University0 个研究点目标入组 15 人开始时间: 2015年7月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Prior invasive non-breast malignancy (except carcinoma in situ) unless disease free for a minimum of 5 years prior to study entry 2) Metachronous or simultaneous bilateral breast cancers 3) Acute infection requiring systemic therapy 4) Body temperature 38 degrees Celsius or more at registration 5) Psychiatric or other condition that would prevent the patient from receiving the protocol therapy 6) Uncontrollable diabetes mellitus or administration of insulin 7) Active or prior history of scleroderma, systemic lupus erythematosus, dermatomyositis, or polymyositis 8) Systemic steroids or immunosuppressant medication 9) Severe heart failure or angina attack or myocardial infarction within the last 6 months 10) Interstitial pneumonia, pulmonary fibrosis, or severe chronic obstructive pulmonary disease 11) Pregnancy, pregnancy potential, after giving birth within 28 days, or lactating

研究者

发起方
Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University

相似试验